Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
This study evaluated renal graft function (based on calcuated creatinine clearance) 12 months
after transplantation in patients receiving either a regimen of reduced dose or standard dose
cyclosporine in combination with sirolimus and corticosteroids. The incidence of acute graft
rejection at 6 and 12 months following transplantation and patient and graft survival at 12
months were evaluated also.